IT1170215B - Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta - Google Patents

Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta

Info

Publication number
IT1170215B
IT1170215B IT22856/83A IT2285683A IT1170215B IT 1170215 B IT1170215 B IT 1170215B IT 22856/83 A IT22856/83 A IT 22856/83A IT 2285683 A IT2285683 A IT 2285683A IT 1170215 B IT1170215 B IT 1170215B
Authority
IT
Italy
Prior art keywords
acute renal
states
treatment
pharmaceutical composition
renal insufficiency
Prior art date
Application number
IT22856/83A
Other languages
English (en)
Italian (it)
Other versions
IT8322856A0 (it
Inventor
Vittorio Bonomini
Original Assignee
Crinos Industria Farmaco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crinos Industria Farmaco filed Critical Crinos Industria Farmaco
Priority to IT22856/83A priority Critical patent/IT1170215B/it
Publication of IT8322856A0 publication Critical patent/IT8322856A0/it
Priority to AT84201286T priority patent/ATE65696T1/de
Priority to EP84201286A priority patent/EP0137542B1/en
Priority to CH4281/84A priority patent/CH661871A5/it
Priority to US06/649,069 priority patent/US4649134A/en
Priority to DE19843433329 priority patent/DE3433329A1/de
Priority to BE0/213640A priority patent/BE900563A/fr
Priority to JP59191390A priority patent/JPH0647546B2/ja
Application granted granted Critical
Publication of IT1170215B publication Critical patent/IT1170215B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT22856/83A 1983-09-12 1983-09-12 Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta IT1170215B (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT22856/83A IT1170215B (it) 1983-09-12 1983-09-12 Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta
AT84201286T ATE65696T1 (de) 1983-09-12 1984-09-07 Verwendung von defibrotid bei der behandlung von zustaenden akuter nierenschwaeche.
EP84201286A EP0137542B1 (en) 1983-09-12 1984-09-07 Use of defibrotide in the treatment of states of acute renal insufficiency
CH4281/84A CH661871A5 (it) 1983-09-12 1984-09-07 Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta.
US06/649,069 US4649134A (en) 1983-09-12 1984-09-10 Pharmaceutical composition containing defibrotide for the treatment of states of acute renal insufficiency
DE19843433329 DE3433329A1 (de) 1983-09-12 1984-09-11 Pharmazeutische zusammensetzung zur behandlung der stadien akuter niereninsuffizienz
BE0/213640A BE900563A (fr) 1983-09-12 1984-09-12 Composition pharmaceutique pour le traitement d'etats d'insuffisance renale aigue.
JP59191390A JPH0647546B2 (ja) 1983-09-12 1984-09-12 医薬組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22856/83A IT1170215B (it) 1983-09-12 1983-09-12 Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta

Publications (2)

Publication Number Publication Date
IT8322856A0 IT8322856A0 (it) 1983-09-12
IT1170215B true IT1170215B (it) 1987-06-03

Family

ID=11201234

Family Applications (1)

Application Number Title Priority Date Filing Date
IT22856/83A IT1170215B (it) 1983-09-12 1983-09-12 Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta

Country Status (8)

Country Link
US (1) US4649134A (enExample)
EP (1) EP0137542B1 (enExample)
JP (1) JPH0647546B2 (enExample)
AT (1) ATE65696T1 (enExample)
BE (1) BE900563A (enExample)
CH (1) CH661871A5 (enExample)
DE (1) DE3433329A1 (enExample)
IT (1) IT1170215B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1170214B (it) * 1983-09-12 1987-06-03 Crinos Industria Farmaco Composizione farmaceutica per la cura delle arteriopatie periferiche
US5223609A (en) * 1986-04-17 1993-06-29 Crinos Industria Farmacobiologica S.P.A. Process for obtaining chemically defined and reproducible polydeoxyribonucleotides
IT1190313B (it) * 1986-04-17 1988-02-16 Crinos Industria Farmaco Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante
IT1223322B (it) * 1987-10-23 1990-09-19 Crinos Industria Farmaco Metodo per prevenire la formazione di coaguli sanguigni nel circuito extracorporeo di apparecchi di dialisi a composizione utile per esso
IT1231509B (it) * 1989-09-07 1991-12-07 Crinos Industria Farmaco Composizione farmceutica ad uso topico per la terapia della fragilita' capillare.
US6699985B2 (en) * 1991-08-21 2004-03-02 Arsinur Burcoglu Method of treating HIV infection and related secondary infections thereof
US5977083A (en) * 1991-08-21 1999-11-02 Burcoglu; Arsinur Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
US5624912A (en) * 1991-08-21 1997-04-29 Burcoglu; Arsinur Method of treating HIV infection and related secondary infections with defibrotide
CA2153778C (en) * 1993-01-13 2004-07-06 Arsinur Burcoglu Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
HK1044896A1 (zh) * 1997-04-28 2002-11-08 Burcoglu Arsinur 治疗hiv感染和与之有关的继发感染的方法
EP1325962A1 (en) * 2001-12-17 2003-07-09 Gentium S.p.A. A method for determining the biological activity of defibrotide
EP1872787A1 (en) * 2006-06-27 2008-01-02 Gentium S.p.A. Use of defibrotide for the inhibition of heparanase
EP1982722A1 (en) * 2007-04-16 2008-10-22 Gentium S.p.A. Use of oligotide for the treatment of renal diseases
US8515557B2 (en) 2007-11-19 2013-08-20 Cochlear Limited Electrode array for a cochlear implant
EP2103689A1 (en) * 2008-03-19 2009-09-23 Gentium S.p.A. Synthetic phosphodiester oligonucleotides and therapeutical uses thereof
IT1406068B1 (it) 2010-07-22 2014-02-06 Medestea Int Spa Polidesossiribonucleotidi (pdrn) per l'impiego nel trattamento di condizioni di acidosi e composizioni a base di polidesossiribonucleotidi per il suddetto impiego
EP2637672B1 (en) 2010-11-12 2018-08-22 Gentium S.r.l. Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (gvhd).
DK2864496T4 (da) * 2012-06-22 2021-01-04 Gentium S R L Euglobulin-baseret fremgangsmåde til bestemmelse af den biologiske aktivitet af defibrotid
EP3026122A1 (en) 2014-11-27 2016-06-01 Gentium S.p.A. Cellular-based method for determining the potency of defibrotide
RU2766143C2 (ru) * 2017-07-26 2022-02-08 Джентиум С.Р.Л. Жидкая композиция дефибротида для лечения и профилактики веноокклюзионной болезни
MX2020001337A (es) * 2017-08-03 2020-09-09 Jazz Pharmaceuticals Ireland Ltd Formulaciones que comprenden un acido nucleico en una alta concentracion.
KR20210008478A (ko) 2018-04-12 2021-01-22 재즈 파마슈티칼즈, 인코포레이티드 면역고갈과 관련된 사이토카인 방출 증후군 및 신경독성의 예방 및 치료를 위한 데피브로타이드
WO2021212055A1 (en) 2020-04-17 2021-10-21 Jazz Pharmaceuticals Ireland Limited Defibrotide treatment for the prevention of organ rejection and injury
WO2022234101A1 (en) 2021-05-06 2022-11-10 Jazz Pharmaceuticals Ireland Limited Defibrotide for the treatment and prevention of acute respiratory distress syndrome

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB879622A (en) * 1959-07-13 1961-10-11 Farmaceutici Italia Steroids
DE1202439B (de) * 1959-11-24 1965-10-07 Cediap Centrale De Destributio Verfahren zur Herstellung von Praeparaten mit hohem Gehalt an freien Desoxyribonucleinsaeuren aus Fischmilch
FR2575M (fr) * 1962-03-19 1964-06-08 Cediap Centrale De Distrib D A Procédé de préparation d'un médicament a base d'adn (acide désoxyribonucléique) en milieu vital d'origine et produit nouveau en résultant.
DE2154279A1 (de) * 1970-11-03 1972-05-25 Crinos Industria Farmaco Medikamente für das fibrinolytische System
IT1043823B (it) * 1970-11-03 1980-02-29 Prephar Procedimento per l estrazione di acidi nucleici da organi animali
US3899481A (en) * 1970-11-03 1975-08-12 Crinos Industria Farmaco Process for the controlled partial degradation of deoxyribonucleic acid extracted from animal organs

Also Published As

Publication number Publication date
JPH0647546B2 (ja) 1994-06-22
ATE65696T1 (de) 1991-08-15
IT8322856A0 (it) 1983-09-12
JPS6084224A (ja) 1985-05-13
CH661871A5 (it) 1987-08-31
EP0137542B1 (en) 1991-07-31
EP0137542A2 (en) 1985-04-17
US4649134A (en) 1987-03-10
BE900563A (fr) 1985-01-02
DE3433329A1 (de) 1985-03-28
EP0137542A3 (en) 1987-09-02
DE3433329C2 (enExample) 1993-07-22

Similar Documents

Publication Publication Date Title
IT1170215B (it) Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta
FR2481703B1 (fr) Acides aminocyclopentane-alcenoiques et leurs esters, leur preparation et utilisation dans des compositions pharmaceutiques
MX9203167A (es) Composicion farmaceutica con actividad analgesica.
IS3284A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
PT66789A (en) Process for the preparation of pharmaceutical compositions having high rate of resorption,from heart glicosides,in se hardly resorptive,to be parenterically administered
IT1167123B (it) Benzoazacicloalchilspiro-imidazolidine,procedimento per prepararle e composizioni farmaceutiche che le contengono
IT7849754A0 (it) Dispositivo per la somministrazione di sostanze medicamentose in particolare ad animali
IL35987A0 (en) Vitamin a acid amides,their preparation and pharmaceutical compositions containing them
CA961041A (en) 1-methyl-3-alkoxymethyl-5,5-disub-stituted barbituric acid compounds and therapeutic compositions containing same
IL37013A (en) Basically substituted alkylidene-aminooxyalkyl-carboxylic acid esters,their preparation and pharmaceutical compositions containing them
BE823513A (fr) Composes diaziniques utilisables notamment comme substances actives de medicaments
FR2580497B1 (fr) Compositions pharmaceutiques en comprimes
GB1464467A (en) Pharmaceutical composition for the treatment of coronary
CA956526A (en) Tool for administering injections to livestock
ES436179A1 (es) Procedimiento para intensificar la eficacia de medicamentos que in vivo o in vitro demuestren una afinidad de enlace a proteinas de la sangre.
ZA718463B (en) Improvements in or relating to pharmaceutical preparations having anaesthetic activity
ZA718465B (en) Improvements in or relating to pharmaceutical preparations having anaesthetic activity
IT1114869B (it) Derivati attivi di metilammina,composizioni terapeutiche che li contengono e procedimenti per preparare i detti derivati e le dette composizioni
ATE87482T1 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
ATE8966T1 (de) Analgetische potenzierung.
CA957280A (en) Progestational composition in oral dosage form
IT8122133A0 (it) Composizione farmaceutica di fosfomicina in compresse da succhiare.
DK131601C (da) Doseringsapparat til blandingsbestanddele i tandfyldninger
IE36780B1 (en) New pharmaceutical preparations

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960910